Roxithromycin is an antibiotic with the active ingredient roxithromycin. It is also known by brand names like Rulide and Roxar. This medication is used to treat various bacterial infections, such as respiratory tract infections, skin infections, and urinary tract infections.
The pricing structure for Roxithromycin is set between £0.63 and £1.02 for every pills. It’s reflective of the size of the packaging and ingredient concentration (30 or 360 mg).
Roxithromycin belongs to the class of medications known as macrolide antibiotics. It functions by inhibiting bacterial protein synthesis, thereby preventing bacterial growth and replication.
Roxithromycin binds to the 50S ribosomal subunit of susceptible bacteria, inhibiting the translocation of peptides. This action disrupts the elongation phase of protein synthesis, leading to bacteriostasis.
Roxithromycin is indicated for the treatment of various bacterial infections, including respiratory tract infections, urinary tract infections, and skin and soft tissue infections. It is also effective against infections caused by atypical pathogens like Mycoplasma pneumoniae and Chlamydia trachomatis.
Roxithromycin is administered orally. The tablets should be swallowed whole with water. It is recommended to take the medication on an empty stomach for optimal absorption, either 30 minutes before or 2 hours after a meal.
The usual dosage for adults is 150 mg twice daily or 300 mg once daily. The duration of treatment typically ranges from 5 to 10 days, depending on the severity and type of infection. Dose adjustments may be necessary for patients with impaired liver function.
Store Roxithromycin at room temperature, between 20°C to 25°C (68°F to 77°F). Keep the medication in a tightly closed container, away from direct sunlight, heat, and moisture. Keep out of reach of children.
Roxithromycin is contraindicated in patients with known hypersensitivity to macrolide antibiotics. It should not be used in individuals with severe hepatic impairment or in those taking concomitant ergot alkaloids due to the risk of ergotism.
Roxithromycin may interact with other medications, including warfarin, theophylline, digoxin, and certain statins, potentially increasing their serum concentrations. Co-administration with strong CYP3A4 inhibitors or inducers may alter Roxithromycin metabolism.
Common adverse effects include gastrointestinal disturbances such as nausea, vomiting, abdominal pain, and diarrhea. Less commonly, dizziness, headache, and hepatotoxicity may occur. In rare cases, severe allergic reactions and QT prolongation have been reported.
Monitor liver function tests periodically in patients receiving prolonged therapy or those with pre-existing liver disease. Regularly assess symptom resolution and bacterial eradication to ensure treatment efficacy. Monitor for signs of adverse effects, especially in high-risk populations.
Advise patients to complete the full course of therapy, even if symptoms improve before the medication is finished. Stress the importance of taking the medication at the same time each day to maintain consistent blood levels. Inform patients to avoid consuming grapefruit juice during treatment as it may interfere with the drug’s efficacy.
Pregnant and breastfeeding women should use Roxithromycin only if the potential benefits justify the potential risks. Dose adjustment may be needed in elderly patients and those with significant renal or hepatic impairment. Pediatric use should be based on a careful assessment of the risk-benefit ratio.
Bacterial resistance to Roxithromycin can occur through various mechanisms, including alteration of the ribosomal target site, efflux pumps, and enzymatic degradation. Cross-resistance with other macrolides may occur, necessitating susceptibility testing for guiding therapy.